NikasDReimersBElisabettaM. Percutaneous interventions in patients with acute ischemic stroke related to obstructive atherosclerotic disease or dissection of the extracranial carotid artery. J Endovasc Ther.2007; 14: 279–288.
2.
ChernyshevOYGaramiZCallejaS. Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke. 2005; 36: 32–37.
3.
RiboMAlvarez-SabinJMontanerJ. Temporal profile of recanalization after intravenous tissue plasminogen activator: Selecting patients for rescue reperfusion techniques. Stroke. 2006; 37: 1000–1004.
4.
SaqqurMUchinoKDemchukAM. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007; 38: 948–954.
5.
RubieraMAlvarez-SabinJRiboM. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005; 36: 1452–1456.
6.
AlbersGWThijsVNWechslerL. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol.2006; 60: 508–517.
7.
FurlanAJEydingDAlbersGW. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006; 37: 1227–1231.
8.
JovinTGGuptaRUchinoK. Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke. 2005; 36: 2426–2430.
9.
SauvageauEHanelRAWehmanJC. Reversal of a 30-h fixed deficit with carotid angioplasty and stenting: Technical note. Neuroradiology. 2006; 48: 259–263.
10.
ZaidatOOAlexanderMJSuarezJI. Early carotid artery stenting and angioplasty in patients with acute ischemic stroke. Neurosurgery. 2004; 55: 1237–1243.
11.
ImaiKMoriTIzumotoH. Emergency carotid artery stent placement in patients with acute ischemic stroke. AJNR Am J Neuroradiol.2005; 26: 1249–1258.
12.
ThomallaGSchwarkCSobeskyJ. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: Comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke. 2006; 37: 852–858.
13.
HackeWAlbersGAl-RawiY. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005; 36: 66–73.
14.
RiboMMolinaCARoviraA. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke. 2005; 36: 602–606.
15.
ProsserJButcherKAllportL. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke. 2005; 36: 1700–1704.
16.
FurlanAHigashidaRWechslerL. Intraarterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282: 2003–2011.
17.
QureshiAIHarris-LanePKirmaniJF. Intraarterial reteplase and intravenous abciximab in patients with acute ischemic stroke: An open-label, dose-ranging, phase I study. Neurosurgery. 2006; 59: 789–797.
18.
QureshiAISuriMFAliZ. Carotid angioplasty and stent placement: A prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002; 50: 466–475.
AdamsHPAdamsRJBrottT. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003; 34: 1056–1083.
21.
DavalosABlancoMPedrazaS. The clinical-DWI mismatch: A new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004; 62: 2187–2192.
